Nkembuh, N. (2026) Symbiotic Communication Systems: Examining the Co-Evolution of Human-AI Communication Patterns in the Digital Age. Journal of Computer and Communications, 14, 1-19. doi: 10.4236/jcc ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

CrowdStrike's 2025 data shows attackers breach AI systems in 51 seconds. Field CISOs reveal how inference security platforms ...

CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...

Anthropic has launched Claude Cowork, bringing AI agent file-manipulation to Claude Max users at $100-200/month, while ...

Health Discovery Corp. is a pattern recognition company, which engages in mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United ...

2026 is highlighted as the year of the singularity with Elon Musk warning of underestimated impacts; conversations with him ...

Health Discovery Corp. is a pattern recognition company, which engages in mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United ...